PROVIDER PROFILE · NPI 1962466565

Xiao MuMD, PHD

PRACTICEPOPLAR HEALTHCARE, PLLCSee all providers at this practice →

PathologyMemphis, TNI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

3,641

Unique beneficiaries

—

Total services

5,299

Distinct HCPCS

Medicare payment

$256K

Peer benchmark

Total Medicare services vs. 319 Pathology providers in TN — top quintile (cohort median 1,853).

PRESCRIBING · PART D · 2024

No data available for this provider in 2024.

QUALITY · MIPS · 2024

Final MIPS score

75.0

Quality

0.0

Cost

0.0

Improvement activities

0.0

Promoting interop.

0.0

Payment adjustment

0.00%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Xiao Mu's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 32 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Mohammad Qureshi Pathology · Edison, NJ	277	375
LAKEWOOD PATHOLOGY ASSOCIATES, INC.	126	159
MEMORIAL HEALTH CARE SYSTEM INC.	100	140
QDX PATH ALLIANCE, PC	86	98
David Sahaj Urology · Chattanooga, TN	73	134
BENTON, OLIVER	73	136
Stephen Jackson Urology · Cleveland, TN	65	108
Kymber Habenicht Urology · Chattanooga, TN	63	123
BYRD, JACK	60	97
JOHNSON, WILLIAM	52	70
Marty Scheinberg Urology · Chattanooga, TN	50	78
Laboratory Corporation Of America Holdings Clinical Laboratory · Birmingham, AL	50	80

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history